When we think about fatty liver, we instantly think of someone who is overweight or obese. It seems logical. Increased body fat must mean excess liver fat. But this notion is dangerously misleading. An increasing amount of research indicates that many individuals with normal body weight too have extra fat in their liver. This disorder is now known as lean MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease). The concerning element is that thin people with fatty liver may actually be more likely than their obese counterparts to die from liver-related causes.
What Exactly Is Lean Fatty Liver?
The presence of extra fat in the liver (steatosis) among people with a normal body mass index (BMI) is called lean fatty liver. This means a BMI of less than 23 kg/m² among most Indians. Roughly 10–20% of all fatty liver instances occur in slim individuals in the world. But the prevalence is considerably higher in Indian communities and it has been found that it can reach up to 22%. According to a recent data analysis, 19.2% of people with NAFLD worldwide were slim and 40.8% were not obese, which is alarming. In India, the “thin-fat phenotype”, where individuals have normal weight but excessive visceral fat, makes this condition particularly relevant.
Why Does This Happen? The Hidden Mechanisms
Several reasons explain why lean individuals develop fatty liver. Most reasons go well beyond basic weight:
- Genetics: Genetic predisposition is the single most important factor. Regardless of BMI, variations in genes such as PNPLA3, TM6SF2, and MBOAT7 greatly enhance sensitivity to hepatic fat formation. The PNPLA3 GG variation has been found to be more prevalent among slim MASLD patients than in obese ones.
- Visceral Fat (The Thin-Fat Phenotype): Even at a normal BMI, Indians have a tendency to accumulate fat around internal organs (visceral fat). This is in contrast to accumulation of fat under the skin. This visceral fat is physiologically active. It induces insulin resistance and liver fat deposition.
- Insulin Resistance: Most lean people with fatty liver have severe insulin resistance. This condition encourages the buildup of fat in the liver though they are not obese.
- Dietary factors: Western-style diet high in saturated fats, high fructose intake (from processed foods and sugary drinks) and a diet deficient in protein are some of the main factors for lean NAFLD.
- Gut Microbiome: Many research shows that lean NAFLD patients have a different gut microbiome composition when compared to obese NAFLD patients. This clearly suggests that gut dysbiosis plays a role.
A Hidden Danger with Serious Consequences
The important issue is that thin fatty liver is not a less severe variant of the illness. Many research indicates that compared to overweight/obese MASLD patients, lean MASLD patients had a higher risk of liver-related mortality. They also had similar risks of cardiovascular events, cirrhosis and liver cancer progression, and all-cause mortality. According to a medical data analysis, 29.2% of lean NAFLD patients had substantial fibrosis (stage ≥2), and 39% developed non-alcoholic steatohepatitis (NASH). Not being obese results in a delayed diagnosis and this factor lets the illness worsen silently.
Diagnosis and Management: What You Can Do
The crucial conclusion is that you cannot rely on BMI alone to measure your liver health. Even if you are not overweight, be screened if you have a family history of diabetes or fatty liver. Also screen yourself for the presence of NAFLD if you have metabolic risk factors like high triglycerides or insulin resistance. Scale weight sometimes can be misleading as it does not take into account the waist circumference.
Management of lean fatty liver focuses on correcting metabolism rather than drastic weight loss:
- Diet: A diet that is abundant in fish, vegetables, legumes, whole grains and olive / coconut oil is very beneficial.
- Activity: To counter Sarcopenia (loss of muscle mass), (found commonly among patients with lean NAFLD), aim for 150–200 minutes of moderate-intensity aerobic activity per week in addition to strength training.
- Steer clear of alcohol and hepatotoxic supplements: Many herbal “liver tonics” can be dangerous and even moderate drinking can hasten the process.
- Medical Management: Lifestyle modifications continue to be the mainstay of treatment, however new medications such as GLP-1 receptor agonists show promise.
Liver Health Screening in Chennai
For residents of Chennai, the prevalence of fatty liver is alarmingly high. A study conducted in a tertiary care center in Chennai found that 61.5% of screened adults aged 21–40 years had NAFLD. Given that South India has the highest prevalence of MASLD in the country (40.1%), lean individuals in Chennai are not exempt. If you are in Chennai and have concerns about your liver health, consult a gastroenterologist or hepatologist even if you are not obese or overweight. Leading hospitals in Chennai offer comprehensive liver screening which can include advanced FibroScan. Early detection is your best defense.